ID   CHD9_HUMAN              Reviewed;        2897 AA.
AC   Q3L8U1; B2RTU2; B9ZVQ0; O15025; Q1WF12; Q6DTK9; Q9H9V7; Q9UHM2;
DT   02-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   12-APR-2017, entry version 121.
DE   RecName: Full=Chromodomain-helicase-DNA-binding protein 9;
DE            Short=CHD-9;
DE            EC=3.6.4.12;
DE   AltName: Full=ATP-dependent helicase CHD9;
DE   AltName: Full=Chromatin-related mesenchymal modulator;
DE            Short=CReMM;
DE   AltName: Full=Chromatin-remodeling factor CHROM1;
DE   AltName: Full=Kismet homolog 2;
DE   AltName: Full=PPAR-alpha-interacting complex protein 320 kDa;
DE   AltName: Full=Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein;
GN   Name=CHD9; Synonyms=KIAA0308, KISH2, PRIC320; ORFNames=AD-013, x0008;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, PHOSPHORYLATION, AND VARIANT GLU-2312.
RC   TISSUE=Bone marrow stroma;
RX   PubMed=16095617; DOI=10.1016/j.jmb.2005.06.049;
RA   Shur I., Benayahu D.;
RT   "Characterization and functional analysis of CReMM, a novel
RT   chromodomain helicase DNA-binding protein.";
RL   J. Mol. Biol. 352:646-655(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, TISSUE SPECIFICITY,
RP   VARIANT GLU-2312, AND INTERACTION WITH PPARA; ESR1 AND NR1I3.
RX   PubMed=16554032; DOI=10.1016/j.bbrc.2006.02.160;
RA   Surapureddi S., Viswakarma N., Yu S., Guo D., Rao M.S., Reddy J.K.;
RT   "PRIC320, a transcription coactivator, isolated from peroxisome
RT   proliferator-binding protein complex.";
RL   Biochem. Biophys. Res. Commun. 343:535-543(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Pharynx carcinoma;
RA   Colin C., Dahia P.L.M., Stiles C.D., Sogayar M.C.;
RT   "Cloning of the mammalian orthologs of Drosophila melanogaster gene
RT   KISMET.";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 124-2897 (ISOFORM 3), AND
RP   VARIANT GLU-2312.
RC   TISSUE=Brain;
RX   PubMed=9205841; DOI=10.1093/dnares/4.2.141;
RA   Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VII.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 4:141-150(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 485-639.
RC   TISSUE=Adrenal gland;
RX   PubMed=10931946; DOI=10.1073/pnas.160270997;
RA   Hu R.-M., Han Z.-G., Song H.-D., Peng Y.-D., Huang Q.-H., Ren S.-X.,
RA   Gu Y.-J., Huang C.-H., Li Y.-B., Jiang C.-L., Fu G., Zhang Q.-H.,
RA   Gu B.-W., Dai M., Mao Y.-F., Gao G.-F., Rong R., Ye M., Zhou J.,
RA   Xu S.-H., Gu J., Shi J.-X., Jin W.-R., Zhang C.-K., Wu T.-M.,
RA   Huang G.-Y., Chen Z., Chen M.-D., Chen J.-L.;
RT   "Gene expression profiling in the human hypothalamus-pituitary-adrenal
RT   axis and full-length cDNA cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9543-9548(2000).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 886-1616.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1468 AND SER-1472, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-550; SER-611 AND
RP   SER-2026, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-550; SER-2058 AND
RP   SER-2059, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-499, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-550; SER-1468 AND
RP   SER-1472, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-550; SER-1468; SER-1472;
RP   SER-2058; SER-2059; SER-2075 AND SER-2079, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-2350, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [17]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-2038, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
CC   -!- FUNCTION: Acts as a transcriptional coactivator for PPARA and
CC       possibly other nuclear receptors. Proposed to be a ATP-dependent
CC       chromatin remodeling protein. Has DNA-dependent ATPase activity
CC       and binds to A/T-rich DNA. Associates with A/T-rich regulatory
CC       regions in promoters of genes that participate in the
CC       differentiation of progenitors during osteogenesis (By
CC       similarity). {ECO:0000250, ECO:0000269|PubMed:16095617,
CC       ECO:0000269|PubMed:16554032}.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O = ADP + phosphate.
CC   -!- SUBUNIT: Interacts with PPARA. Probably interacts with ESR1 and
CC       NR1I3. {ECO:0000269|PubMed:16554032}.
CC   -!- INTERACTION:
CC       Q07869:PPARA; NbExp=2; IntAct=EBI-960730, EBI-78615;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16095617}.
CC       Nucleus {ECO:0000269|PubMed:16095617}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q3L8U1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q3L8U1-2; Sequence=VSP_018086;
CC       Name=3;
CC         IsoId=Q3L8U1-3; Sequence=VSP_018085, VSP_018086;
CC   -!- TISSUE SPECIFICITY: Widely expressed at low levels. In bone
CC       marrow, expression is restricted to osteoprogenitor cells adjacent
CC       to mature osteoblasts. {ECO:0000269|PubMed:16095617,
CC       ECO:0000269|PubMed:16554032}.
CC   -!- PTM: Phosphorylated on serine and tyrosine residues.
CC       {ECO:0000269|PubMed:16095617}.
CC   -!- SIMILARITY: Belongs to the SNF2/RAD54 helicase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF24170.1; Type=Erroneous translation; Note=Wrong choice of frame.; Evidence={ECO:0000305};
CC       Sequence=BAB14112.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY243500; AAQ24287.1; -; mRNA.
DR   EMBL; DQ333316; ABD24032.1; -; mRNA.
DR   EMBL; AY647157; AAT66509.1; -; mRNA.
DR   EMBL; AC007906; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC079416; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC140815; AAI40816.1; -; mRNA.
DR   EMBL; AB002306; BAA20767.3; -; mRNA.
DR   EMBL; AF150735; AAF24170.1; ALT_SEQ; mRNA.
DR   EMBL; AK022582; BAB14112.1; ALT_INIT; mRNA.
DR   CCDS; CCDS45485.1; -. [Q3L8U1-2]
DR   CCDS; CCDS76865.1; -. [Q3L8U1-1]
DR   RefSeq; NP_001295248.1; NM_001308319.1. [Q3L8U1-1]
DR   RefSeq; NP_079410.4; NM_025134.4. [Q3L8U1-2]
DR   RefSeq; XP_005256229.1; XM_005256172.3. [Q3L8U1-2]
DR   RefSeq; XP_016879210.1; XM_017023721.1. [Q3L8U1-1]
DR   RefSeq; XP_016879211.1; XM_017023722.1. [Q3L8U1-3]
DR   RefSeq; XP_016879212.1; XM_017023723.1. [Q3L8U1-2]
DR   UniGene; Hs.59159; -.
DR   UniGene; Hs.622347; -.
DR   ProteinModelPortal; Q3L8U1; -.
DR   SMR; Q3L8U1; -.
DR   BioGrid; 123174; 25.
DR   IntAct; Q3L8U1; 19.
DR   STRING; 9606.ENSP00000455307; -.
DR   iPTMnet; Q3L8U1; -.
DR   PhosphoSitePlus; Q3L8U1; -.
DR   BioMuta; CHD9; -.
DR   DMDM; 215273951; -.
DR   EPD; Q3L8U1; -.
DR   MaxQB; Q3L8U1; -.
DR   PaxDb; Q3L8U1; -.
DR   PeptideAtlas; Q3L8U1; -.
DR   PRIDE; Q3L8U1; -.
DR   Ensembl; ENST00000398510; ENSP00000381522; ENSG00000177200. [Q3L8U1-1]
DR   Ensembl; ENST00000447540; ENSP00000396345; ENSG00000177200. [Q3L8U1-1]
DR   Ensembl; ENST00000564845; ENSP00000455307; ENSG00000177200. [Q3L8U1-2]
DR   Ensembl; ENST00000566029; ENSP00000457466; ENSG00000177200. [Q3L8U1-2]
DR   GeneID; 80205; -.
DR   KEGG; hsa:80205; -.
DR   UCSC; uc002egy.4; human. [Q3L8U1-1]
DR   CTD; 80205; -.
DR   DisGeNET; 80205; -.
DR   GeneCards; CHD9; -.
DR   HGNC; HGNC:25701; CHD9.
DR   HPA; HPA042053; -.
DR   HPA; HPA049420; -.
DR   neXtProt; NX_Q3L8U1; -.
DR   OpenTargets; ENSG00000177200; -.
DR   PharmGKB; PA128394727; -.
DR   eggNOG; KOG0384; Eukaryota.
DR   eggNOG; COG0553; LUCA.
DR   GeneTree; ENSGT00760000119067; -.
DR   HOVERGEN; HBG081150; -.
DR   InParanoid; Q3L8U1; -.
DR   KO; K14438; -.
DR   OMA; PGAATDY; -.
DR   OrthoDB; EOG091G0022; -.
DR   PhylomeDB; Q3L8U1; -.
DR   TreeFam; TF313572; -.
DR   Reactome; R-HSA-1368082; RORA activates gene expression.
DR   Reactome; R-HSA-1368108; BMAL1:CLOCK,NPAS2 activates circadian gene expression.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-2032785; YAP1- and WWTR1 (TAZ)-stimulated gene expression.
DR   Reactome; R-HSA-2151201; Transcriptional activation of mitochondrial biogenesis.
DR   Reactome; R-HSA-2426168; Activation of gene expression by SREBF (SREBP).
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   Reactome; R-HSA-400206; Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha).
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   GeneWiki; CHD9; -.
DR   GenomeRNAi; 80205; -.
DR   PRO; PR:Q3L8U1; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000177200; -.
DR   CleanEx; HS_CHD9; -.
DR   ExpressionAtlas; Q3L8U1; baseline and differential.
DR   Genevisible; Q3L8U1; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0004386; F:helicase activity; IEA:UniProtKB-KW.
DR   GO; GO:0044255; P:cellular lipid metabolic process; TAS:Reactome.
DR   GO; GO:0016569; P:covalent chromatin modification; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR006576; BRK_domain.
DR   InterPro; IPR000953; Chromo/chromo_shadow_dom.
DR   InterPro; IPR023780; Chromo_domain.
DR   InterPro; IPR016197; Chromodomain-like.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000330; SNF2_N.
DR   Pfam; PF07533; BRK; 2.
DR   Pfam; PF00385; Chromo; 2.
DR   Pfam; PF00271; Helicase_C; 1.
DR   Pfam; PF00176; SNF2_N; 1.
DR   SMART; SM00592; BRK; 2.
DR   SMART; SM00298; CHROMO; 2.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   SUPFAM; SSF54160; SSF54160; 2.
DR   PROSITE; PS50013; CHROMO_2; 2.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Chromatin regulator;
KW   Complete proteome; Cytoplasm; DNA-binding; Helicase; Hydrolase;
KW   Isopeptide bond; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN         1   2897       Chromodomain-helicase-DNA-binding protein
FT                                9.
FT                                /FTId=PRO_0000233172.
FT   DOMAIN      690    761       Chromo 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00053}.
FT   DOMAIN      773    839       Chromo 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00053}.
FT   DOMAIN      872   1046       Helicase ATP-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00541}.
FT   DOMAIN     1186   1337       Helicase C-terminal.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00542}.
FT   NP_BIND     885    892       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00541}.
FT   REGION     2332   2481       Binds A/T-rich DNA.
FT   REGION     2429   2436       A.T hook-like.
FT   MOTIF       868    872       LXXLL motif 1.
FT   MOTIF       997   1000       DEAH box.
FT   MOTIF      1036   1040       LXXLL motif 2.
FT   MOTIF      2031   2035       LXXLL motif 3.
FT   MOTIF      2721   2725       LXXLL motif 4.
FT   MOTIF      2793   2798       LXXLL motif 5.
FT   COMPBIAS    220    312       Ser-rich.
FT   COMPBIAS    562    666       Lys-rich.
FT   COMPBIAS   2128   2198       Ser-rich.
FT   COMPBIAS   2639   2650       Poly-Ala.
FT   COMPBIAS   2785   2788       Poly-Ala.
FT   COMPBIAS   2878   2888       Poly-Ser.
FT   MOD_RES     499    499       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     550    550       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     611    611       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1468   1468       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1472   1472       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2026   2026       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    2058   2058       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2059   2059       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2075   2075       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2079   2079       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK   2038   2038       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25772364}.
FT   CROSSLNK   2350   2350       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447}.
FT   VAR_SEQ    2206   2206       R -> RA (in isoform 3).
FT                                {ECO:0000303|PubMed:9205841}.
FT                                /FTId=VSP_018085.
FT   VAR_SEQ    2336   2351       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:16554032,
FT                                ECO:0000303|PubMed:9205841,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_018086.
FT   VARIANT    2312   2312       D -> E (in dbSNP:rs6499548).
FT                                {ECO:0000269|PubMed:16095617,
FT                                ECO:0000269|PubMed:16554032,
FT                                ECO:0000269|PubMed:9205841}.
FT                                /FTId=VAR_047355.
FT   CONFLICT     98    100       SQF -> PQL (in Ref. 3; AAT66509).
FT                                {ECO:0000305}.
FT   CONFLICT    119    119       S -> P (in Ref. 3; AAT66509).
FT                                {ECO:0000305}.
FT   CONFLICT    208    208       V -> A (in Ref. 3; AAT66509).
FT                                {ECO:0000305}.
FT   CONFLICT    473    473       L -> I (in Ref. 3; AAT66509).
FT                                {ECO:0000305}.
FT   CONFLICT    836    836       R -> C (in Ref. 2; ABD24032 and 6;
FT                                BAA20767). {ECO:0000305}.
FT   CONFLICT   1072   1072       A -> V (in Ref. 2; ABD24032 and 8;
FT                                BAB14112). {ECO:0000305}.
FT   CONFLICT   1122   1122       S -> F (in Ref. 3; AAT66509).
FT                                {ECO:0000305}.
FT   CONFLICT   1372   1372       S -> P (in Ref. 3; AAT66509).
FT                                {ECO:0000305}.
FT   CONFLICT   1442   1442       S -> G (in Ref. 2; ABD24032 and 8;
FT                                BAB14112). {ECO:0000305}.
FT   CONFLICT   1724   1724       A -> T (in Ref. 3; AAT66509).
FT                                {ECO:0000305}.
FT   CONFLICT   1754   1754       S -> L (in Ref. 3; AAT66509).
FT                                {ECO:0000305}.
FT   CONFLICT   1867   1867       T -> A (in Ref. 3; AAT66509).
FT                                {ECO:0000305}.
FT   CONFLICT   2025   2025       A -> V (in Ref. 3; AAT66509).
FT                                {ECO:0000305}.
FT   CONFLICT   2069   2069       T -> A (in Ref. 3; AAT66509).
FT                                {ECO:0000305}.
FT   CONFLICT   2078   2078       V -> G (in Ref. 3; AAT66509).
FT                                {ECO:0000305}.
FT   CONFLICT   2189   2189       S -> F (in Ref. 3; AAT66509).
FT                                {ECO:0000305}.
FT   CONFLICT   2759   2759       S -> N (in Ref. 3; AAT66509).
FT                                {ECO:0000305}.
FT   CONFLICT   2776   2776       T -> A (in Ref. 1; AAQ24287 and 6;
FT                                BAA20767). {ECO:0000305}.
SQ   SEQUENCE   2897 AA;  326022 MW;  91884A5E2F8ED183 CRC64;
     MTDPMMDFFD DANLFGETLE GLSDDAFVQP GPVSLVDELN LGAEFEPLHI DSLNHVQGTP
     THQKMTDFEQ LNQFDSIKFH HVNQSFGSPA EHVLSPHSQF NCSPIHPQNQ PNGLFPDVSD
     GSPMWGHQTA TTISNQNGSP FHQQGHSHSM HQNKSFVAHH DFALFQANEQ QTQCTSLRSQ
     QNRNNLNPGQ NSLSQSKNFM NVSGPHRVNV NHPPQMTNAS NSQQSISMQQ FSQTSNPSAH
     FHKCSSHQEG NFNGPSPNMT SCSVSNSQQF SSHYSFSSNH ISPNSLLQSS AVLASNHTNQ
     TLSDFTGSNS FSPHRGIKQE STQHILNPNT SLNSNNFQIL HSSHPQGNYS NSKLSPVHMN
     FPDPVDSGTQ MGHFNDHVET NGFSSLEENL LHQVESQTEP FTGLDPEDLL QEGLLPHFDE
     STFGQDNSSH ILDHDLDRQF TSHLVTRPSD MAQTQLQSQA RSWHSSFSNH QHLHDRNHLC
     LQRQPPSSKK SDGSGTYTKL QNTQVRVMSE KKQRKKVESE SKQEKANRII SEAIAKAKER
     GERNIPRVMS PENFPTASVE GKEEKKGRRM KSKPKDKDSK KTKTCSKLKE KTKIGKLIIT
     LGKKQKRKNE SSDEISDAEQ MPQHTLKDQD SQKRRSNRQI KRKKYAEDIE GKQSEEEVKG
     SMKIKKNSAP LPGEQPLQLF VENPSEEDAA IVDKILSSRT VKKEISPGVM IDTEEFFVKY
     KNYSYLHCEW ATEEQLLKDK RIQQKIKRFK LRQAQRAHFF ADMEEEPFNP DYVEVDRVLE
     VSFCEDKDTG EPVIYYLVKW CSLPYEDSTW ELKEDVDLAK IEEFEQLQAS RPDTRRLDRP
     PSNIWKKIDQ SRDYKNGNQL REYQLEGLNW LLFNWYNRRN CILADEMGLG KTIQSITFLY
     EILLTGIRGP FLIIAPLSTI ANWEREFRTW TDINVVVYHG SLISRQMIQQ YEMYFRDSQG
     RIIRGAYRFQ AIITTFEMIL GGCGELNAIE WRCVIIDEAH RLKNKNCKLL EGLKLMNLEH
     KVLLTGTPLQ NTVEELFSLL HFLEPLRFPS ESTFMQEFGD LKTEEQVQKL QAILKPMMLR
     RLKEDVEKKL APKEETIIEV ELTNIQKKYY RAILEKNFSF LSKGAGQTNV PNLVNTMMEL
     RKCCNHPYLI KGAEEKILGE FRDTYNPAAS DFHLQAMIQS AGKLVLIDKL LPKMKAGGHK
     VLIFSQMVRC LDILEDYLIH KRYLYERIDG RVRGNLRQAA IDRFSKPDSD RFVFLLCTRA
     GGLGINLTAA DTCIIFDSDW NPQNDLQAQA RCHRIGQNKA VKVYRLVTRN SYEREMFDRA
     SLKLGLDKAV LQSMSGRESN VGGIQQLSKK EIEDLLRRGA YGAIMEEEDE GSKFCEEDID
     QILLRRTKTI TIESEGRGST FAKASFVASG NRTDISLDDP NFWQKWAKKA EIDIEAISGR
     NSLVIDTPRI RKQTRPFSAT KDELAELSEA ESEGDEKPKL RRPCDRSNGY GRTECFRVEK
     NLLVYGWGRW REILSHGRFK RQLNEHDVEI ICRALLAYCL VHYRGDEKIK GFIWDLITPT
     EDGQTRELQN HLGLSAPVPR GRKGKKVKTQ TSSFDIQKAE WLRKYNPEQL LQDEGYKKHI
     KHHCNKVLLR VRMLYYLKQE VIGNECQKVF DGVDASDIDV WVPEPDHSEV PAEWWDFDAD
     KSLLIGVFKH GYEKYNTIRA DPALCFLERV GKPDEKAVAA EQRANDYMDG DVEDPEYKPA
     PAIFKDDIED DVSSPGDLVI ADGDGQLMEG DKVYWPTQSA LTTRLRRLIT AYQRTNKNRQ
     IQQIQPTFSV PTSVMQPIYE EATLNPKMAA KIERQQRWTR REEADFYRVV STFGVVFDPD
     RGQFDWTKFR AMARLHKKTD DSLEKYLYAF MSMCRRVCRL PSKEELVDPN IFIQPITEER
     ASRTLYRIEL LRKVREQALR HPQLFERLKL CHPNPDLPVW WECGPHDRDL LIGAAKHGVS
     RTDYHILRDP ELSFMAAQRN YSQSKMAHSR TSTPLLQQYQ VALSASPLTS LPRLLDAKGI
     ILEEMKVKSE NLKEEPQSSE EESMSSVETR TLIKSEPVSP KNGVLPQATG DQKSGGKCET
     DRRMVAARTE PLTPNPASKK PRVHKRGSES SSDSDSDSER SSCSSRSSSS SSSSSCSHSR
     SGSSSSSSSS CSSASSSSSS STSSSSSSSS SSSEESDSDE EEAQKRESTT HMKAYDEESV
     ASLSTTQDET QDSFQMNNGT PESAYILQGG YMLAASYWPK DRVMINRLDS ICQTVLKGKW
     PSARRSYDAN TVASFYTTKL LDSPGAATEY SDPSVPTPPG AGVKEEHDQS TQMSKVKKHV
     REKEFTVKIK DEGGLKLTFQ KQGLAQKRPF DGEDGALGQQ QYLTRLRELQ SASETSLVNF
     PKSIPVSGTS IQPTLGANGV ILDNQPIVKK RRGRRKNVEG VDIFFFNRNK PPNHVSLGLT
     SSQISTGINP ALSYTQPQGI PDTESPVPVI NLKDGTRLAG DDAPKRKDLE KWLKEHPGYV
     EDLGAFIPRM QLHEGRPKQK RHRCRNPNKL DVNSLTGEER VQLINRRNAR KVGGAFAPPL
     KDLCRFLKEN SEYGVAPEWG DVVKQSGFLP ESMYERILTG PVVREEVSRR GRRPKSGIAK
     ATAAAAAASA TSVSGNPLLA NGLLPGVDLT TLQALQQNLQ NLQSLQVTAG LMGMPTGLPS
     GGEAKNMAAM FPMLLSGMAG LPNLLGMGGL LTKPTESGTE DKKGSDSKES EGKTERTESQ
     SSENGGENSV SSSPSTSSTA ALNTAAAANP LALNPLLLSN ILYPGMLLTP GLNLHIPTLS
     QSNTFDVQNK NSDLGSSKSV EVKEEDSRIK DQEDKGGTEP SPLNENSTDE GSEKADASSG
     SDSTSSSSED SDSSNED
//
